MedPath
FDA Approval

Herceptin

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Genentech, Inc.
DUNS: 080129000
Effective Date
October 19, 2020
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Trastuzumab(150 mg in 7.4 mL)

Manufacturing Establishments3

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Roche Singapore Technical Operations Pte. Ltd.

Genentech, Inc.

937189173

Roche Diagnostics GmbH

Genentech, Inc.

315028860

Genentech, Inc.

Genentech, Inc.

146373191

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Herceptin

Product Details

NDC Product Code
50242-132
Application Number
BLA103792
Marketing Category
BLA (C73585)
Route of Administration
INTRAVENOUS
Effective Date
October 19, 2020
HISTIDINE MONOHYDROCHLORIDE MONOHYDRATEInactive
Code: X573657P6PClass: IACTQuantity: 3.4 mg in 7.4 mL
HISTIDINEInactive
Code: 4QD397987EClass: IACT
Code: P188ANX8CKClass: ACTIBQuantity: 150 mg in 7.4 mL
TREHALOSE DIHYDRATEInactive
Code: 7YIN7J07X4Class: IACT
POLYSORBATE 20Inactive
Code: 7T1F30V5YHClass: IACT
© Copyright 2025. All Rights Reserved by MedPath